{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:15:48Z","timestamp":1787958948061,"version":"build-2784847793"},"reference-count":55,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jjcc.2021.11.012","type":"journal-article","created":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T15:47:31Z","timestamp":1639064851000},"page":"698-702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Management of hypertension associated with cardiovascular failure"],"prefix":"10.1016","volume":"79","author":[{"given":"Shunsuke","family":"Kiuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2021.11.012_bib0001","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1253\/circj.72.489","article-title":"Impending epidemic: future projection of heart failure in Japan to the year 2055","volume":"72","author":"Okura","year":"2008","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0002","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/ejhf.1629","article-title":"Prevalence of heart failure and left ventricular dysfunction in China: the China hypertension Survey, 2012\u20132015","volume":"21","author":"Hao","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0003","unstructured":"Guidelines for diagnosis and treatment of acute and chronic heart failure (JCS 2017\/JHFS 2017), https:\/\/www.j-circ.or.jp\/guideline\/pdf\/JCS2017_tsutsui_h\/pdf, Accessed 15 September 2021."},{"key":"10.1016\/j.jjcc.2021.11.012_bib0004","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1901281","article-title":"SPRINT Research Group. Final Report of a Trial of Intensive versus Standard Blood-Pressure Control","volume":"384","author":"Lewis","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0005","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMoa2111437","article-title":"STEP study Group. Trial of intensive blood-pressure control in older patients with hypertension","volume":"385","author":"Zhang","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0006","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1093\/eurheartj\/ehy287","article-title":"Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120\u2013140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and Transcend trials","volume":"39","author":"B\u00f6hm","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0007","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","article-title":"The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019)","volume":"42","author":"Umemura","year":"2019","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0008","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1093\/eurheartj\/ehx525","article-title":"The effect of sacubitril\/valsartan compared to olmesartan on cardiovascular remodeling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study","volume":"38","author":"Schmieder","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0009","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1161\/CIRCULATIONAHA.117.028441","article-title":"Effect of intensive blood pressure lowering on left ventricular hypertrophy in patients with hypertension: SPRINT (Systolic Blood Pressure Intervention Trial)","volume":"136","author":"Soliman","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0010","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0735-1097(01)01663-1","article-title":"Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study","volume":"38","author":"Verdecchia","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0011","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/HJH.0000000000000848","article-title":"Effects of blood pressure-lowering treatment. 6. Prevention of heart failure and new-onset heart failure\u2013meta-analyses of randomized trials","volume":"34","author":"Thomopoulos","year":"2016","journal-title":"J Hypertens"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0012","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mayocp.2015.10.019","article-title":"Angiotensin converting enzyme inhibitors or angiotensin receptor blockers in patients without heart failure? Insights from 254,301 patients from randomized trials","volume":"91","author":"Bangalore","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0013","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1161\/CIRCULATIONAHA.116.025950","article-title":"Angiotensin receptor blockers reduce cardiovascular events, including the risk of myocardial infarction","volume":"135","author":"Messerli","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0014","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/ehf2.12612","article-title":"The transition from hypertension to hypertensive heart disease and heart failure: the PREFERS hypertension study","volume":"7","author":"Ekstr\u00f6m","year":"2020","journal-title":"E.S.C. Heart Fail"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0015","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/ejhf.805","article-title":"Prognostic value of long-term blood pressure changes in patients with chronic heart failure","volume":"19","author":"Schmid","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0016","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1536\/ihj.49.691","article-title":"The profile and prognosis of patients hospitalized with heart failure. The value of discharge blood pressure and cholesterol","volume":"49","author":"Jindrich","year":"2008","journal-title":"Int Heart J"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0017","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1253\/circj.CJ-13-0725","article-title":"Usefulness of combined risk stratification with heart rate and systolic blood pressure in the management of chronic heart failure. A report from the CHART-2 study","volume":"77","author":"Miura","year":"2013","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0018","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007475","article-title":"Diastolic blood pressure and adverse outcomes in the TOPCAT (treatment of preserved cardiac function heart failure with an aldosterone antagonist) trial","volume":"7","author":"Sandesara","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0019","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jchf.2017.08.015","article-title":"Reverse J-curve relationship between on-treatment blood pressure and mortality in patients with heart failure","volume":"5","author":"Lee","year":"2017","journal-title":"J.A.C.C. Heart Fail"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0020","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.jacc.2020.02.009","article-title":"Systolic blood pressure in heart failure with preserved ejection fraction treated with Sacubitril\/Valsartan","volume":"75","author":"Selvaraj","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0021","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ahj.2006.02.038","article-title":"The pathophysiology of acute heart failure - is it all about fluid accumulation?","volume":"155","author":"Cotter","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0022","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s11517-017-1775-y","article-title":"Fluid mechanics of Windkessel effect","volume":"56","author":"Mei","year":"2018","journal-title":"Med Biol Eng Comput"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0023","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s10439-011-0443-x","article-title":"Systolic hypertension mechanisms: effect of global and local proximal aorta stiffening on pulse pressure","volume":"40","author":"Reymond","year":"2012","journal-title":"Ann Biomed Eng"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0024","first-page":"432","article-title":"Heart failure with preserved ejection fraction","volume":"115","author":"Rogers","year":"2015","journal-title":"J Am Osteopath Assoc"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0025","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1097\/01.CCM.0000296274.51933.4C","article-title":"Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes","volume":"36","author":"Mebazaa","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0026","doi-asserted-by":"crossref","first-page":"732","DOI":"10.5551\/jat.RV17043","article-title":"New horizons of arterial stiffness developed using cardio-ankle vascular index (CAVI)","volume":"27","author":"Saiki","year":"2020","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0027","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1620\/tjem.240.57","article-title":"Vascular Physiology according to Clinical Scenario in Patients with Acute Heart Failure: evaluation using the Cardio-Ankle Vascular Index","volume":"240","author":"Goto","year":"2016","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0028","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1253\/circrep.CR-18-0013","article-title":"Clinical scenario classification for characterization and outcome prediction of acute decompensated heart failure under contemporary phenotyping","volume":"1","author":"Komuro","year":"2019","journal-title":"Circ Rep"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0029","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.hfc.2007.10.001","article-title":"Ventricular-vascular interaction in heart failure","volume":"4","author":"Borlaug","year":"2008","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0030","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s00380-020-01633-w","article-title":"Cardio-ankle vascular index predicts the 1-year prognosis of heart failure patients categorized in clinical scenario 1","volume":"35","author":"Sano","year":"2020","journal-title":"Heart Vessels"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0031","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jchf.2018.11.011","article-title":"Target doses of heart failure medical therapy and blood pressure: insights from the CHAMP-HF registry","volume":"7","author":"Peri-Okonny","year":"2019","journal-title":"J.A.C.C. Heart Fail"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0032","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1253\/circj.CJ-21-0335","article-title":"Differences in priorities for heart failure management between cardiologists and general practitioners in Japan","volume":"85","author":"Kinugasa","year":"2021","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0033","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1253\/circj.CJ-19-0227","article-title":"Efficacy and safety of ivabradine in Japanese patients with chronic heart failure - J-SHIFT Study","volume":"83","author":"Tsutsui","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0034","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.jacc.2019.02.015","article-title":"Titration of medical therapy for heart failure with reduced ejection fraction","volume":"73","author":"Greene","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0035","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jchf.2018.11.019","article-title":"Prevalence and prognostic implications of longitudinal ejection fraction change in heart failure","volume":"7","author":"Savarese","year":"2019","journal-title":"J.A.C.C. Heart Fail"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0036","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006667","article-title":"Treatment differences in chronic heart failure patients with reduced ejection fraction according to blood pressure","volume":"13","author":"Veenis","year":"2020","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0037","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s40261-021-01004-x","article-title":"Efficacy and safety of ivabradine in an elderly patient with heart failure with reduced ejection fraction","volume":"41","author":"Kiuchi","year":"2021","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0038","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4103\/jcecho.jcecho_6_17","article-title":"The role of ivabradine in Diastolic Heart Failure with preserved Ejection Fraction. A Doppler-Echocardiographic study","volume":"27","author":"Cacciapuoti","year":"2017","journal-title":"J Cardiovasc Echogr"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0039","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijcard.2017.12.093","article-title":"Optimization of heart rate lowering therapy in hospitalized patients with heart failure: insights from the Optimize Heart Failure Care Program","volume":"260","author":"Lopatin","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0040","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2169\/internalmedicine.6061-20","article-title":"Implication of ivabradine in up-titrating beta-blocker in a patient with advanced heart failure","volume":"60","author":"Hori","year":"2021","journal-title":"Intern Med"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0041","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/eurjhf\/hfr020","article-title":"Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial","volume":"13","author":"D\u00fcngen","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0042","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jconrel.2018.09.024","article-title":"Molecular mechanism of ion-pair releasing from acrylic pressure sensitive adhesive containing carboxyl group: roles of doubly ionic hydrogen bond in the controlled release process of bisoprolol ion-pair","volume":"289","author":"Zhao","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0043","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/10641963.2020.1723616","article-title":"Bisoprolol transdermal patch improves orthostatic in patients with chronic heart failure and hypertension","volume":"42","author":"Kiuchi","year":"2020","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0044","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0045","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/ejhf.1835","article-title":"Management of low blood pressure in ambulatory heart failure with reduced ejection fraction patients","volume":"22","author":"Cautela","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0046","article-title":"Beta blockers up-titration in patients with heart failure reduced ejection fraction and cardiac resynchronization therapy, a Single Center study","volume":"7","author":"Masarone","year":"2019","journal-title":"Med Sci (Basel)"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0047","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00380-015-0711-z","article-title":"Prognostic significance of beta-blocker up-titration in conjunction with cardiac resynchronization therapy in heart failure management","volume":"31","author":"Nabeta","year":"2016","journal-title":"Heart Vessels"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0048","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ejheart.2004.09.009","article-title":"Success of a multidisciplinary heart failure clinic for initiation and up-titration of key therapeutic agents","volume":"7","author":"Jain","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0049","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jacc.2017.11.041","article-title":"Biomarker-guided versus guideline-based treatment of patients with heart failure: results from BioStat-CHF","volume":"71","author":"Ouwerkerk","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0050","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015042","article-title":"Real-world analysis of guideline-based therapy after hospitalization for heart failure","volume":"9","author":"Wirtz","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0051","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.amjcard.2013.08.013","article-title":"Uptitration of renin-angiotensin system blocker and beta-blocker therapy in patients hospitalized for heart failure with reduced versus preserved left ventricular ejection fractions","volume":"112","author":"Verbrugge","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0052","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ijcard.2017.02.070","article-title":"Current use of guideline-based medical therapy in elderly patients admitted with acute heart failure with reduced ejection fraction and its impact on event-free survival","volume":"235","author":"Akita","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0053","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jchf.2020.08.017","article-title":"Heart failure hospitalization and guideline-directed prescribing patterns among heart failure with reduced ejection fraction patients","volume":"9","author":"Srivastava","year":"2021","journal-title":"J.A.C.C. Heart Fail"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0054","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.amjcard.2018.01.006","article-title":"Effect of optimizing guideline-directed medical therapy before discharge on mortality and heart failure readmission in patients hospitalized with heart failure with reduced ejection fraction","volume":"121","author":"Yamaguchi","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2021.11.012_bib0055","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jchf.2015.03.008","article-title":"Effects of beta-blocker withdrawal in acute decompensated heart failure: A Systematic Review and Meta-Analysis","volume":"3","author":"Prins","year":"2015","journal-title":"J.A.C.C. Heart Fail"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S091450872100321X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S091450872100321X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:06:09Z","timestamp":1760274369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S091450872100321X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S091450872100321X"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2021.11.012","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of hypertension associated with cardiovascular failure","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2021.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Japanese College of Cardiology. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}